Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vaxart

For some small biotechs, the race to develop a COVID-19 vaccine represented an opportunity to secure funding and establish partnerships that could serve as lifelines long after the pandemic. Two companies who have been eager to take advantage are Inovio Pharmaceuticals (NASDAQ: IRead MoreMarketsMarkets Feed